GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Filament Health Corp (NEOE:FH) » Definitions » Inventories, Raw Materials & Components

Filament Health (NEOE:FH) Inventories, Raw Materials & Components : C$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Filament Health Inventories, Raw Materials & Components?

Filament Health's inventories, raw materials & components for the quarter that ended in Dec. 2024 was C$0.00 Mil.


Filament Health Inventories, Raw Materials & Components Historical Data

The historical data trend for Filament Health's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Filament Health Inventories, Raw Materials & Components Chart

Filament Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
- - - - -

Filament Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Filament Health Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Filament Health Business Description

Industry
Traded in Other Exchanges
Address
4475 Wayburne Drive, Unit 210, Burnaby, BC, CAN, V5G 4X4
Filament Health Corp is a natural psychedelic drug development company. Its mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. The group engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.
Executives
Benjamin Lightburn Director, Senior Officer
Thomas Kineshanko 10% Security Holder
Warren Duncan Senior Officer

Filament Health Headlines

No Headlines